Tapewire
HeatmapsAnalyticsCompareCompaniesCountriesPeopleETFsSectorsIndustriesWatchlistPortfolioTerminalScreenerBrokersToolsLearnGlossaryMethodologyAPIPricing

CRESCENT BIOPHARMA, INC. — insider transactions

2 transactions on record · CBIO · CIK 1253689

Aggregates

computed from the filings below
Purchases, 12m
2
count of open-market buys
Sales, 12m
0
count of open-market sales
Buy / sell ratio, 12m
—
no sales recorded
Distinct insiders, 12m
1
Bought, 3m
$20M
Sold, 3m
$0
Median disclosure lag
4.0 d
trade date to filing date
Largest single trade, 24m
$12.4M
2026-07-16
Director share, 12m
100.0%
of transactions where role is stated
Current run
2 buys
consecutive same-direction transactions
Net 3m flow
$20M
purchases minus sales
Total on record
2

Transactions

2 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-07-202026-07-164Harwin Peter EvanDirector, 10% OwnerOpen market purchase525,897$14.50$7.6Mfiling
2026-07-202026-07-164Harwin Peter EvanDirector, 10% OwnerOpen market purchase853,450$14.50$12.4Mfiling

Source: U.S. Securities and Exchange Commission, EDGAR

CRESCENT BIOPHARMA, INC. insider transactions — 2 filings on record — Tapewire